CTMX icon

CytomX Therapeutics
CTMX

Overview Fund Activity

122 hedge funds and large institutions have $698M invested in CytomX Therapeutics in 2018 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 55 increasing their positions, 31 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
122
Holders Change
-20
Holders Change %
-14.08%
% of All Funds
2.79%
Holding in Top 10
1
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-75%
% of All Funds
0.02%
New
14
Increased
55
Reduced
31
Closed
34
Calls
$724K
Puts
$1.62M
Net Calls
-$900K
Net Calls Change
-$2.44M

Top Buyers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
$24.6M
2
Fidelity Investments
Fidelity Investments
Massachusetts
$125M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
$75.6M
4
Victory Capital Management
Victory Capital Management
Texas
$16.5M
5
PA
Perceptive Advisors
New York
$49.2M

Top Sellers

1
TCP
Tourbillon Capital Partners
New York
$0
2
Invesco
Invesco
Georgia
$1.63M
3
RG
Redmile Group
California
$0
4
Man Group
Man Group
United Kingdom
$3.26M
5
Russell Investments Group
Russell Investments Group
United Kingdom
$467K
Name Holding Trade Value Shares
Change 		Shares
Change %
PS
151
Portfolio Strategies
New York
– -$10K -425 Closed
CF
152
Centaurus Financial
California
– -$9K -400 Closed
QI
153
QS Investors
New York
– -$8K -370 Closed
CG
154
Cutler Group
California
– -$2K -100 Closed
IA
155
IFP Advisors
Florida
– -$1K -44 Closed
TRCT
156
Tower Research Capital (TRC)
New York
– -$1K -35 Closed
3 4 5 6
7